Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death
Our retrospective cohort study suggests that clinical coding is a digital intervention associated with a lower adjusted hazard of death and COVID-19 death in patients with CKD stages 3 and 4, and should be considered a key element in the organisation and delivery of care for people with CKD.
Authors
- Thomas Blakeman (ORCID: https://orcid.org/0000-0003-3298-8423)
- Stuart Stewart (ORCID: https://orcid.org/0000-0002-7767-4308)
- Evangelos Kontopantelis (ORCID: https://orcid.org/0000-0001-6450-5815)
- George Tilston (ORCID: https://orcid.org/0000-0003-1475-5888)
- Smeeta Sinha (ORCID: https://orcid.org/0000-0003-4117-4085)
- Philip A. Kalra
Institutions
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- Northern Health and Social Care Trust (GB)
- National Institute for Health and Care Excellence (GB)
- National Institute for Health and Care Research (GB)
- NIHR Manchester Biomedical Research Centre (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1371/journal.pone.0333881
- Primary Topic
- Healthcare cost, quality, practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00